Add To Watchlist
Share URL
Hikma Pharmaceuticals PLC
HIK.L: LSELowest reading is at 20 out of 100. All scores are out of 100.
In Short
About The Company
CEO
H.E Said Darwazah
Market Cap
3.29 Billion GBp
Sector
Healthcare
Website
https://www.hikma.comLast Update
27/09/2026, 18:06:00
Description
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
Read More
Strongest readings
- ✔Price-to-earnings of 11.9 is below the market average of 19.6
- ✔Debt is low at 0.77 times equity
Weakest readings
- ✘Earnings and cashflow growth is weak (growth score 20 out of 100)
- ✘The current price sits above estimated fair value (margin of safety -41.82%)
Key Figures
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✔ | Price / earnings (TTM) | 11.91x | 19.60x | |
| ✘ | Margin of safety (DCF) | -41.82% | 17.95% | |
| ✘ | Revenue growth (5y average) | 0.00% | 10.97% | |
| ✔ | Dividend yield (TTM) | 4.22% | 1.85% | |
| ✔ | Share count, per year | 0.00% | 0.00% | |
| ✘ | Return on capital employed | 3.44% | 10.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Valuation
84 / 100Priced at or below the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✔ | Price / earnings | 11.91x | 19.60x | |
| ✘ | Free cashflow yield | 4.38% | 4.70% | |
| Price / earnings growth | N/A | 1.50x | ||
| Price / book | 129.69x | — | ||
| ✘ | Margin of safety | -41.82% | 17.95% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Estimated intrinsic value of 925.07 GBp is below the current price of 1.59 Thousand GBp
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Estimated Fair Value: 23.3 GBp ✘
Current Price: 1590 GBp
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.
Growth
20 / 100Growing more slowly than the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Revenue growth | 0.00% | 10.97% | |
| ✘ | Earnings growth | 0.00% | 14.48% | |
| ✘ | Cashflow growth | 0.00% | 12.35% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Health
40 / 100Balance sheet is stretched on several measures.
Measured on Leverage and capital, Funding and liquidity, Earnings quality.
| Status | Metric | Value | Reading | Threshold |
|---|---|---|---|---|
| ✘ | Altman-Z score | 1.12 | 3.00 | |
| ✔ | Piotroski score | 5.00 | 5.00 | |
| ✔ | Debt / equity | 0.77x | 0.80x | |
| ✔ | Current ratio | 1.98x | 1.00x | |
| ✔ | Interest coverage | 6.11x | 2.50x | |
| ✘ | Free cashflow / debt | 0.02x | 0.15x | |
| ✔ | Debt / capital | 0.44x | 1.00x |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Dividend
62 / 100Covered, with limited headroom.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✔ | Dividend yield | 4.22% | 1.85% | |
| ✔ | Dividend growth | 0.00% | 0.00% | |
| ✘ | Payout ratio (earnings) | 47.55% | 40.00% | |
| ✘ | Payout ratio (cashflow) | 96.34% | 65.00% | |
| ✔ | Worst year, last 5 years | 0.00% | -2.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Management
54 / 100Returns on capital are at or above the market.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Return on equity | 3.81% | 15.00% | |
| ✘ | Return on capital employed | 3.44% | 10.00% | |
| Return on assets | 1.66% | — | ||
| Free cashflow return on capital | 1.07% | — | ||
| ✘ | Return on capital, 5y change | -0.93% | 0.00% | |
| ✔ | Share count, per year | 0.00% | 0.00% | |
| ✔ | Share count, recent | -5.32% | 0.00% | |
| Realized buyback return | N/A | 0.00% | ||
| ✔ | Goodwill erosion / equity | 0.16% | 2.00% | |
| Price volatility, 5 year | 31.64% | — |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Analysts
not enough data| Status | Metric | Value | Reading | Neutral |
|---|---|---|---|---|
| Analyst opinion score | N/A | 50 |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Financial History
Annual figures across the full reporting history we hold.
Market Peers
HIK.L
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
See 35+ Years Annual ReportsOther Information
Company Name
Hikma Pharmaceuticals PLC
Currency
GBp
Beta
0.662
Vol Avg
931499
Ceo
H.E Said Darwazah
Cik
Cusip
Exchange
LSE
Full Time Employees
9500
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Ipo Date
Address
10 Portman Square
City
London
State
Country
United Kingdom
Zip
W1H 6AZ
Phone
44 20 7399 2760
Analysis Last Updated
27/09/2026, 18:06:00
Financial data compiled from SEC EDGAR filings and Yahoo Finance.